Walls E V, Crawford D H
Hatfield Polytechnic, Herts, U.K.
Leuk Res. 1990;14(4):389-91. doi: 10.1016/0145-2126(90)90168-9.
Immortalization of chronic leukaemic B cells by Epstein-Barr virus (EBV) was investigated. Immortalization resistant and susceptible cell populations were defined by chronic lymphocytic leukaemia (CLL) and prolymphocytic leukaemia (PLL) cells respectively. These cell types could be distinguished by the effects of a phorbol ester on [3H]-thymidine incorporation by EBV-infected cells. A synergistic effect was observed in the non-immortalizing CLL samples, whereas this response was inhibited in the immortalizing PLL. Under the conditions used in the study, TPA did not cooperate with EBV to immortalize CLL cells.
研究了爱泼斯坦-巴尔病毒(EBV)对慢性白血病B细胞的永生化作用。分别以慢性淋巴细胞白血病(CLL)和幼淋巴细胞白血病(PLL)细胞定义了永生化抗性和敏感细胞群体。这些细胞类型可通过佛波酯对EBV感染细胞掺入[3H] - 胸腺嘧啶核苷的影响来区分。在非永生化的CLL样本中观察到协同效应,而在永生化的PLL中这种反应受到抑制。在该研究使用的条件下,佛波酯不能与EBV协同使CLL细胞永生化。